Ivey Publishing

Product Details

McKesson Corporation: Pharmaceutical Distribution Industry
Product Number:
Publication Date:
Revised Date:
27 pages (7 pages of text)
Product Type:
Case (Pub Mat)
On October 27, 2017, the share price of McKesson Corporation and two other major US pharmaceutical distributors dropped by 7–12 per cent over only a few days. The stock price drop was fuelled by reports that Amazon Inc. had quietly acquired wholesales pharmacy licences in 12 US states and, a short time later, formed an independent venture with Berkshire Hathaway Inc. and JP Morgan Chase & Co. to improve the cost and quality of health care for the US employees of all three companies. These two notable events in the US pharmaceuticals market did not go unnoticed by a group of students enrolled in a value investing class, who wondered if it was possible for Amazon Inc. to disrupt the US health care industry, or if the market was overreacting to the two reports. Was McKesson Corporation’s future in the pharmaceutical distribution business in jeopardy, or was its stock suddenly in a favourable buy position?
Learning Objective:
This case is suitable for use in undergraduate- and graduate-level courses on value investing. After completion of this case and assignment questions, students will be able to:
  • Identify and describe the conditions for relaxing the screening or assessment criteria for a company.
  • Describe the pharmaceutical industry and its competitive landscape.
  • Quantitatively assess the value of a company by using various valuation models.
  • Identify competitive moats and their sustainability within an industry.
  • Assess a company’s risk management initiatives and effectiveness.
    Finance,  International
    Health Care Services
    United States, Large, 2018
    Intended Audience:
    $5.30 CAD / $5.00 USD Printed Copy
    $4.50 CAD / $4.25 USD Permissions
    $4.50 CAD / $4.25 USD Digital Download
    Associated Materials
    Supplements: 7B20N017 (177 KB)
    You Might Also Like...

    Save In: